HomeACRS • NASDAQ
add
Aclaris Therapeutics Inc
Previous close
$1.56
Day range
$1.53 - $1.65
Year range
$0.99 - $5.17
Market cap
175.96M USD
Avg Volume
699.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.46M | -39.32% |
Operating expense | 6.14M | -10.30% |
Net income | -15.08M | 10.96% |
Net profit margin | -1.04K | -46.76% |
Earnings per share | -0.12 | 50.00% |
EBITDA | -17.76M | -11.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 105.31M | -17.83% |
Total assets | 198.09M | 13.80% |
Total liabilities | 54.03M | 68.57% |
Total equity | 144.07M | — |
Shares outstanding | 108.28M | — |
Price to book | 1.17 | — |
Return on assets | -21.25% | — |
Return on capital | -29.18% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.08M | 10.96% |
Cash from operations | -13.06M | 37.27% |
Cash from investing | 19.12M | 13.58% |
Cash from financing | -275.00K | -400.00% |
Net change in cash | 5.79M | 243.35% |
Free cash flow | -9.55M | 41.28% |
About
Founded
2012
Website
Employees
63
